cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Ratna Kumalasari
Contact Email
medicinus@dexagroup.com
Phone
+6287808191388
Journal Mail Official
medicinus@dexagroup.com
Editorial Address
Gedung Titan Center 5th Floor, Jl. Boulevard Bintaro B7/B1 No. 5, Bintaro Jaya Sektor 7, Pokdok Aren, Tangerang Selatan 15224
Location
Kota tangerang selatan,
Banten
INDONESIA
MEDICINUS
Published by PT Dexa Medica
ISSN : 1979391X     EISSN : 29638399     DOI : 10.56951
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health
Tujuan penerbitan jurnal Medicinus adalah untuk meningkatkan wawasan dan menambah khasanah pengetahuan para praktisi medis dan farmasis di bidang kedokteran dan kefarmasian. Ruang lingkup dari jurnal ilmiah ini adalah publikasi artikel-artikel ilmiah yang bisa disajikan dalam bentuk penelitian (research), laporan kasus (case report), teknologi dan klinis kefarmasian, serta ulasan literatur medis.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 179 Documents
 11   12   13   14   15 
Nutritional Intervention in Osteoporosis: An Overlooked Management in Primary Care Muhammad Gifari Rasyidi; Mohammad Wibowo Ariyanto; Ahmad Fakar Sanusi Rasyid; Elvan Wiyarta
MEDICINUS Vol. 38 No. 3 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/9fh08k72

Abstract

Osteoporosis is a bone disease with a high global mortality rate. Typically, it affects adults and the elderly, particularly postmenopausal women. Normally, bone thinning and decreased bone mineral density are consequences of aging. Osteoporosis leads to significant decrease in quality of life and an increase in the incidence of fractures. In this condition, bone formation and resorption must be in balance for optimal bone remodeling. Numerous factors affect this mechanism, but one has frequently been overlooked: the deficiency of nutrients such as vitamin D, calcium, and other micronutrients that could help maintaining healthy bone remodeling. The effect of nutrition on bone formation and the prevention of bone loss is synergistic. Therefore, supplementation and nutritional sufficiency monitoring in individuals at risk for osteoporosis can be one prudent action. Most therapeutic focus in Indonesia remains exclusively concentrated on curative pharmacotherapy. This article aims to review the existing literature on nutritional interventions to prevent and slow the progression of the disease, as well as raising awareness regarding the urgency to take preventive measures in osteoporosis management.
Terapi Osteoporosis Terbaru: Tinjauan Komprehensif Farmakologis Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 3 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/d4enjy05

Abstract

Osteoporosis adalah penyakit metabolik tulang yang ditandai dengan penurunan massa dan gangguan mikroarsitektur tulang sehingga meningkatkan risiko fraktur. Pendekatan farmakologis terbaru mencakup agen antiresorptif seperti bisphosphonates dan denosumab, serta terapi anabolik seperti teriparatide dan romosozumab yang berperan dalammeningkatkan kepadatan mineral tulang. Selain pengobatan, suplementasi kalsium dan vitamin D serta modifikasi gaya hidup berperan dalam pencegahan dan pengelolaan osteoporosis. Pemantauan berkala terhadap kepadatan tulang dan efektivitas terapi diperlukan untuk menyesuaikan strategi pengobatan secara personalisasi dan meminimalkan efek samping. Dengan integrasi terapi berbasis biomarker, pendekatan multidisiplin dalam pengelolaan osteoporosis dapat semakin ditingkatkan untuk meningkatkan kualitas hidup pasien.
Nyeri Neuropati: Tantangan dan Perkembangan dalam Manajemen Berbasis Bukti Raymond R Tjandrawinata
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/fqbssh75

Abstract

Nyeri neuropati merupakan kondisi kronis akibat disfungsi sistem saraf somatosensori yang memerlukan pendekatan terapi multimodal untuk mengoptimalkan manajemen nyeri. Pregabalin, sebagai agen farmakoterapi utama, bekerja dengan menurunkan eksitabilitas neuron melalui modulasi kanal kalsium tipe alfa-2-delta, menunjukkan efektivitas dalam mengurangi gejala nyeri neuropati dengan profil farmakokinetik yang lebih unggul dibandingkan gabapentin. Pendekatan nonfarmakologis, seperti cognitive behavioral therapy (CBT) dan stimulasi listrik noninvasif, juga berperan dalam meningkatkan kualitas hidup pasien. Dengan berkembangnya penelitian terhadap agen terapi baru seperti cannabinoid dan mirogabalin, serta pendekatan berbasis personalisasi, strategi manajemen nyeri neuropati terus mengalami inovasi untuk meningkatkan efektivitas dan tolerabilitas terapi.
The Gastroprotective Effect of DLBS2411 for High-Risk Gastrointestinal Patients: Case Series in Inflammatory Pain Condition Rizaldy Taslim Pinzon; Abraham Al Jody; Nicholas Adriel Pinzon
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/6197xj25

Abstract

Chronic pain is a common and distressing problem for the population. The cyclooxygenase (COX)-2 selective and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in managing acute and chronic pain. Research has provided a greater understanding of the risks of gastrointestinal, cardiovascular, and renal events associated with NSAID use. Proton pump inhibitors (PPIs) are widely prescribed due to their gastroprotective effects in NSAID users. However, PPIs also have several acid-inhibition-related and unrelated adverse effects that limit their use in high-risk patients. We report five patients suffering from painful inflammatory pain (flare rheumatoid arthritis, painful knee bursitis, and osteoarthritis). In this case series we evaluate the use of DLBS2411 as an alternative to PPIs. Our study suggests that DLBS2411 can be a safe alternative to PPIs for gastrointestinal high-risk patients who require anti-inflammatory agents.
Herpes Zoster Ophthalmicus with Unilateral Blepharoconjunctivitis: Clinical Presentation and Management Aulia Dewi Priwindrasari; Hermansyah Salim
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/65hcat17

Abstract

Introduction: Herpes zoster develops in individuals who have previously had chickenpox because both conditions arecaused by the same virus, the varicella zoster virus (VZV). After recovering from chickenpox, the virus remains dormant in the sensory ganglia and can reactivate when the immune system becomes weakened. Case: A 13-year-old girl presented with complaints of reddish bumps, which are reported to be itchy and painful, lasting for approximately 4 days. This patient has no history of varicella disease but exhibits symptoms of herpes zoster. Treatment is provided to suppress the progression of the disease, as well as to manage and prevent further complications. Conclusion: Herpes zoster ophthalmicus (HZO) results from the reactivation of the VZV in the ophthalmic branch of the trigeminal nerve. Individuals with weakened immunity, particularly older adults, are at higher risk. HZO can lead to various ocular complications such as conjunctivitis, blepharoconjunctivitis, keratitis, and uveitis. Early antiviral treatment can reduce the severity and duration of symptoms, prevent complications, and minimize the risk of postherpetic neuralgia. Proper management, including antiviral therapy, pain control, and eye care, is crucial to improve clinical outcomes.
Disease-Modifying Therapy (DMT) Switch in Highly Active Multiple Sclerosis: A Case Report Rocksy Fransisca V Situmeang; Nadia Gabriella
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/jx5d6764

Abstract

Background: Highly active multiple sclerosis (HAMS) is a severe phenotype of multiple sclerosis (MS), accounting for 10% of all relapsing-remitting MS (RRMS) cases, characterized by rapid clinical decline and disease progression despite treatment with disease-modifying therapy (DMT). It is associated with high morbidity and mortality rates, thus requiring different therapeutic approaches. We report a case of DMT switch in a 30-year-old female with HAMS. Case: A 30-year-old female presented with a 3-month history of numbness and tingling on her fingers, back, and lower extremities. Examination revealed hyperreflexia and positive Hoffman-Tromner sign. Brain magnetic resonance imaging (MRI) revealed multiple demyelinating lesions suggestive of MS, including Dawson’s fingers. She was diagnosed with MS and initially treated with subcutaneous (SC) interferon beta-1a (IFNβ-1a) 22 mcg, three times weekly. As the patient continued to experience relapses and develop new lesions on biannual repetition of scans, she was diagnosed with RRMS. Four years after the initial diagnosis, her relapses became more frequent with incomplete recovery in between, suggestive of HAMS. Therapy was subsequently switched from IFNβ-1a to cladribine. Conclusion: Two approaches in the treatment of MS are the escalation and induction therapy. To date, no standardized treatment protocols for HAMS have been established. Patients with HAMS are candidates for the induction approach due to the narrow window of opportunity for treatment and the risk of early disease progression. Despite the risk of developing adverse reactions from being on potent immunosuppressive drugs, the imminent neurological disability that comes with HAMS outweighs this risk. The use of immune-reconstitution DMTs helps to achieve no evidence of disease activity (NEDA). Cladribine has shown promising outcomes in the treatment of HAMS and is frequently used for induction therapy.
Kemajuan dalam Biologi Spasial: Perspektif Multiomik Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/54mmsr80

Abstract

Biologi spasial telah muncul sebagai bidang transformatif, memberikan wawasan yang belum pernah terjadi sebelumnya tentang organisasi spasial biomolekul, sel, dan jaringan. Ulasan ini mengkaji kemajuan dalam multiomik spasial antara tahun 2020 hingga 2025, dengan fokus pada teknologi utama, termasuk imunofluoresensi multipleks (multiplex immunofluorescence/mIF), mikroskopi lembaran cahaya, dan transkriptomik spasial. Inovasi-inovasi ini memungkinkan analisis multidimensi resolusi tinggi terhadap sistem biologis yang kompleks, merevolusi penelitian kanker, studi mikrobioma, dan ilmu saraf. Integrasi antara omik sel tunggal dan spasial telah memberikan pemahaman yang lebih dalam mengenai heterogenitas tumor, distribusi sel imun, dan interaksi seluler dalam lingkungan mikro tumor. Selain itu, multiomik spasial telah memperluas aplikasi di luar onkologi, menawarkan wawasan baru dalam biologi liver, sirkuit saraf, dan mikrobioma usus. Namun demikian, dengan adanya kemajuan ini, tetap terdapat tantangan dalam analisis data, integrasi, dan aksesibilitas. Evolusi berkelanjutan alat komputasi, analisis berbasis kecerdasan buatan, dan integrasi multiomik akan semakin meningkatkan dampak bidang ini, serta membuka jalan bagi pengobatan yang lebih personal dan terapi presisi.
Melawan Penurunan Kognitif pada Otak yang Menua Lewat Pemulihan Fungsi Mitokondria Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/wdpk3k28

Abstract

Mitokondria, pabrik energi sel, memainkan peran penting dalam menjaga fungsi neuron dan sirkuit melalui produksi adenosine triphosphate (ATP) melalui fosforilasi oksidatif (oxidative phosphorylation/OXPHOS). Dalam otak mamalia yang menua, efisiensi OXPHOS menurun, menyebabkan disfungsi mitokondria, stres oksidatif, dan penurunan kognitif. Penelitian terbaru menyoroti hubungan antara eksitasi neuron dan transkripsi gen mitokondria, menunjukkan bahwa keterkaitan ini berkurang seiring bertambahnya usia. Studi lain memperkuat temuan ini dan menawarkan perspektif yang lebih luas tentang mekanisme yang mendasari disfungsi mitokondria pada penuaan serta strategi terapeutik potensial. Ulasan ini mengkaji penelitian-penelitian mutakhir untuk memberikan pemahaman komprehensif tentang penurunan mitokondria terkait usia dan dampaknya terhadap fungsi kognitif.
Cervicofacial Subcutaneous Emphysema Post-Dental Procedure in A Three-Year-Old Patient: A Case Report saputera, christina
MEDICINUS Vol. 38 No. 7 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/e61psx91

Abstract

Background : Dental procedures can cause several serious complications such as cervicofacial subcutaneous emphysema, which can be fatal if not diagnosed quickly; especially in children, this is a rare case. Most of cases of cervicofacial subcutaneous emphysema present with symptoms similar to angioedema in cases of allergies, leading to misdiagnosis and delayed treatment. This case is unique because cervicofacial subcutaneous emphysema occurred before invasive dental procedures, which consisted of cleaning using a water spray. Case was taken from pediatric patient who came to the Emergency Room (ER) presented with a chief complaint swelling in the left eye area, spread to the left cheek and neck. Oxygen therapy, pain relievers, antihistamines, and antibiotics eliminate symptoms within 4 days without complications. Diagnosis carried out quickly and precisely followed by appropriate treatment results in good and complete recovery rates.  
Preeklamsia dan Dampaknya dalam Perspektif Psikologi, Sosiologi, dan Medis Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 5 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/wbqkwr31

Abstract

Preeklamsia merupakan komplikasi kehamilan serius yang berdampak multidimensional terhadap kesehatan ibu dan janin. Secara medis, kondisi ini ditandai oleh hipertensi pascausia kehamilan 20 minggu serta temuan proteinuria atau gangguan organ lain, dan dapat menyebabkan komplikasi seperti gagal organ, kelahiran prematur, hingga kematian maternal dan neonatal. Di sisi psikologis, diagnosis preeklamsia sering memicu kecemasan, depresi, dan stres mendalam akibat ketidakpastian terhadap kondisi kehamilan, yang memperburuk kualitas hidup ibu. Sementara itu, dari perspektif sosiologis, preeklamsia mencerminkan ketimpangan sosioekonomi, terutama di negara berkembang, di mana akses terhadap perawatan kesehatan yang memadai masih terbatas. Kurangnya edukasi, ketidakmerataan distribusi fasilitas medis, serta beban sosial terhadap keluarga semakin memperparah dampak kondisi ini. Oleh karena itu, pendekatan interdisipliner yang mencakup intervensi medis, dukungan psikososial, dan kebijakan publik yang progresif sangat penting untuk pencegahan dan penanganan preeklamsia secara komprehensif.

Page 13 of 18 | Total Record : 179

 11   12   13   14   15 

Filter by Year

2020 2025


Reset
Filter By Issues
All Issue Vol. 38 No. 12 (2025): MEDICINUS Vol. 38 No. 11 (2025): MEDICINUS Vol. 38 No. 10 (2025): MEDICINUS Vol. 38 No. 9 (2025): MEDICINUS Vol. 38 No. 8 (2025): MEDICINUS Vol. 38 No. 7 (2025): MEDICINUS Vol. 38 No. 6 (2025): MEDICINUS Vol. 38 No. 5 (2025): MEDICINUS Vol. 38 No. 4 (2025): MEDICINUS Vol. 38 No. 3 (2025): MEDICINUS Vol. 38 No. 2 (2025): MEDICINUS Vol. 38 No. 1 (2025): MEDICINUS Vol. 37 No. 3 (2024): MEDICINUS Vol. 37 No. 2 (2024): MEDICINUS Vol. 37 No. 1 (2024): MEDICINUS Vol. 36 No. 3 (2023): MEDICINUS Vol. 36 No. 2 (2023): MEDICINUS Vol. 36 No. 1 (2023): MEDICINUS Vol. 35 No. 3 (2022): MEDICINUS Vol. 35 No. 2 (2022): MEDICINUS Vol. 35 No. 1 (2022): MEDICINUS Vol. 34 No. 3 (2021): MEDICINUS Vol. 34 No. 2 (2021): MEDICINUS Vol. 34 No. 1 (2021): MEDICINUS Vol 34 No 1 (2021): MEDICINUS Vol. 33 No. 3 (2020): MEDICINUS Vol. 33 No. 2 (2020): MEDICINUS Vol. 33 No. 1 (2020): MEDICINUS More Issue